The calcitonin levels can sometimes mislead parathyroid surgeons in patients with chronic kidney disease and renal hyperparathyroidism: report of a case

被引:1
作者
Schneider, Ralph [1 ]
Schaumburg, Johanna E. [2 ]
Bartsch, Detlef K. [1 ]
Schlosser, Katja [1 ]
机构
[1] Univ Marburg, Dept Visceral Thorac & Vasc Surg, D-35043 Marburg, Germany
[2] Univ Marburg, Dept Gastroenterol, D-35043 Marburg, Germany
关键词
Calcitonin; Renal hyperparathyroidism; Medullary thyroid carcinoma; Chronic kidney disease; MEDULLARY-THYROID CARCINOMA; SERUM CALCITONIN; MANAGEMENT; DIAGNOSIS; CONSENSUS; NODULES;
D O I
10.1007/s00595-012-0131-y
中图分类号
R61 [外科手术学];
学科分类号
摘要
Renal hyperparathyroidism (rHPT) as a consequence of an abnormal calcium balance is a frequent complication in patients with chronic kidney disease (CKD). However, calcium homeostasis is also regulated by calcitonin. The relevance of elevated calcitonin levels in patients with rHPT is unclear. This report presents a case of a patient with CKD and mild rHPT scheduled for thyroidectomy for a suspected medullary thyroid carcinoma (MTC) within a mononodular goiter. A hemithyroidectomy with resection of both adjacent parathyroid glands and unilateral central lymph node dissection was performed. Histopathology revealed no evidence of MTC. The rHPT, calcitonin and pentagastrin test subsequently normalized and follow-up revealed no evidence for MTC within the remaining right thyroid lobe. Elevated calcitonin levels in patients with CKD may reflect a physiological response to rHPT than rather represent MTC. The thresholds for calcitonin levels need to be better defined in affected patients to determine the optimal extent of surgical resection.
引用
收藏
页码:429 / 433
页数:5
相关论文
共 32 条
  • [1] Embryonic parathyroid rests occur commonly and have implications in the management of secondary hyperparathyroidism
    Aly, A
    Douglas, M
    [J]. ANZ JOURNAL OF SURGERY, 2003, 73 (05) : 284 - 288
  • [2] [Anonymous], 2003, THYROID, V13, P3
  • [3] Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma
    Bockhorn, M
    Frilling, A
    Rewerk, S
    Liedke, M
    Dirsch, O
    Schmid, KW
    Broelsch, CE
    [J]. THYROID, 2004, 14 (06) : 468 - 470
  • [4] Calcitonin concentrations in patients with chronic kidney disease and medullary thyroid carcinoma or c-cell hyperplasia
    Borchhardt, K. A.
    Heinzl, H.
    Gessl, A.
    Hoerl, W. H.
    Kaserer, K.
    Sunder-Plassmann, G.
    [J]. KIDNEY INTERNATIONAL, 2006, 70 (11) : 2014 - 2020
  • [5] Continuing controversies in the management of thyroid nodules
    Castro, MR
    Gharib, H
    [J]. ANNALS OF INTERNAL MEDICINE, 2005, 142 (11) : 926 - 931
  • [6] Calcitonin measurement in the evaluation of thyroid nodules in the United States: A cost-effectiveness and decision analysis
    Cheung, Kevin
    Roman, Sanziana A.
    Wang, Tracy S.
    Walker, Hugh D.
    Sosa, Julie Ann
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (06) : 2173 - 2180
  • [7] General weakness as an indication for parathyroid surgery in patients with secondary hyperparathyroidism
    Chou, FF
    Lee, CH
    Chen, JB
    [J]. ARCHIVES OF SURGERY, 1999, 134 (10) : 1108 - 1111
  • [8] Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules
    Costante, Giuseppe
    Meringolo, Domenico
    Durante, Cosimo
    Bianchi, Davide
    Nocera, Maria
    Tumino, Salvatore
    Crocetti, Umberto
    Attard, Marco
    Maranghi, Marianna
    Torlontano, Massimo
    Filetti, Sebastiano
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (02) : 450 - 455
  • [9] Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease
    Demers, LM
    Spencer, CA
    [J]. CLINICAL ENDOCRINOLOGY, 2003, 58 (02) : 138 - 140
  • [10] Regulation of cell growth mediated by the calcitonin receptor
    Findlay, D. M.
    [J]. CELLULAR AND MOLECULAR BIOLOGY, 2006, 52 (03) : 3 - 8